New Journal Issue, VOL. 47 NO. 4, 2017, Now On-Line

ALL ARTICLES: 

Persisting Psychosocial Impairments in Adults Being Treated with Medication for Attention Deficit/Hyperactivity Disorder
By Thomas E. Brown, Emuella Flood, Phillip Sarocco, Norman Atkins, Alexandra Khachatryan

Unmet Medication Coverage Needs among Adults with Attention Deficit/Hyperactivity Disorder (ADHD)
By Thomas E. Brown, Emuella Flood, Phillip Sarocco, Norman Atkins, Alexandra Khachatryan

A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant
By Ryan Dammerman, Sonnie Kim, Mathews Adera, Alex Schwarz

A Phase 1, Open-Label, Single Dose Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant
By Ryan Dammerman, Sonnie Kim, Mathews Adera, Alex Schwarz

Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review
By Sandip P. Tarpada, Matthew T. Morris

Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric Pharmacist
By Dorothy Gotlib, Jolene R. Bostwick, Seema Calip, Elizabeth Perelstein, Jacob E. Kurlander, Thomas Fluent

Dextromethorphan in Cough Syrup: The Poor Man’s Psychosis
By Bridgette Martinak, Ramy A. Bolis, Jeffrey Ryne Black, Rachel E. Fargason, Badari Birur

Escitalopram Induced SIADH in an Elderly Female: A Case Study
By Sudha Vidyasagar, Karthik Rao, Muralidhar Verma, Aswini Dutt Tripuraneni, Navin Patil, Dipanjan Bhattacharjee

By | 2017-09-13T15:19:02+00:00 September 13th, 2017|Brainscience Blogs|0 Comments

About the Author:

Leave A Comment